These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15792635)

  • 1. Anti-opsonic properties of staphylokinase.
    Rooijakkers SH; van Wamel WJ; Ruyken M; van Kessel KP; van Strijp JA
    Microbes Infect; 2005 Mar; 7(3):476-84. PubMed ID: 15792635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b.
    Koch TK; Reuter M; Barthel D; Böhm S; van den Elsen J; Kraiczy P; Zipfel PF; Skerka C
    PLoS One; 2012; 7(10):e47638. PubMed ID: 23071827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus anthracis interacts with plasmin(ogen) to evade C3b-dependent innate immunity.
    Chung MC; Tonry JH; Narayanan A; Manes NP; Mackie RS; Gutting B; Mukherjee DV; Popova TG; Kashanchi F; Bailey CL; Popov SG
    PLoS One; 2011 Mar; 6(3):e18119. PubMed ID: 21464960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus: Staphylokinase.
    Bokarewa MI; Jin T; Tarkowski A
    Int J Biochem Cell Biol; 2006; 38(4):504-9. PubMed ID: 16111912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase.
    Mölkänen T; Tyynelä J; Helin J; Kalkkinen N; Kuusela P
    FEBS Lett; 2002 Apr; 517(1-3):72-8. PubMed ID: 12062412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.
    Amdahl H; Haapasalo K; Tan L; Meri T; Kuusela PI; van Strijp JA; Rooijakkers S; Jokiranta TS
    PLoS One; 2017; 12(3):e0172675. PubMed ID: 28273167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection.
    Kwieciński J; Josefsson E; Mitchell J; Higgins J; Magnusson M; Foster T; Jin T; Bokarewa M
    J Infect Dis; 2010 Oct; 202(7):1041-9. PubMed ID: 20726765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections.
    Peetermans M; Vanassche T; Liesenborghs L; Claes J; Vande Velde G; Kwiecinksi J; Jin T; De Geest B; Hoylaerts MF; Lijnen RH; Verhamme P
    BMC Microbiol; 2014 Dec; 14():310. PubMed ID: 25515118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional basis of plasminogen activation by staphylokinase.
    Jespers L; Vanwetswinkel S; Lijnen HR; Van Herzeele N; Van Hoef B; Demarsin E; Collen D; De Maeyer M
    Thromb Haemost; 1999 Apr; 81(4):479-85. PubMed ID: 10235424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization of yeast cells with equine iC3b, C3b, and IgG.
    Gröndahl G; Johannisson A; Jensen-Waern M; Nilsson Ekdahl K
    Vet Immunol Immunopathol; 2001 Aug; 80(3-4):209-23. PubMed ID: 11457475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of staphylokinase in the acquisition of plasmin(ogen)-dependent enzymatic activity by staphylococci.
    Christner RB; Boyle MD
    J Infect Dis; 1996 Jan; 173(1):104-12. PubMed ID: 8537646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T; Bokarewa M; Zhu Y; Tarkowski A
    Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylokinase Control of Staphylococcus aureus Biofilm Formation and Detachment Through Host Plasminogen Activation.
    Kwiecinski J; Peetermans M; Liesenborghs L; Na M; Björnsdottir H; Zhu X; Jacobsson G; Johansson BR; Geoghegan JA; Foster TJ; Josefsson E; Bylund J; Verhamme P; Jin T
    J Infect Dis; 2016 Jan; 213(1):139-48. PubMed ID: 26136471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding and uptake of single and dual-opsonized targets by macrophages.
    Naik U; Nguyen QPH; Harrison RE
    J Cell Biochem; 2020 Jan; 121(1):183-199. PubMed ID: 31172552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis of target particles bearing C3b-IgG covalent complexes by human monocytes and polymorphonuclear leucocytes.
    Fries LF; Siwik SA; Malbran A; Frank MM
    Immunology; 1987 Sep; 62(1):45-51. PubMed ID: 3653927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylokinase production by clinical Staphylococcus aureus strains.
    Wieckowska-Szakiel M; Sadowska B; Rózalska B
    Pol J Microbiol; 2007; 56(2):97-102. PubMed ID: 17650679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonic activity of immunoglobulin prepared for intravenous use.
    Hetherington SV; Giebink GS
    J Lab Clin Med; 1984 Dec; 104(6):977-86. PubMed ID: 6502004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism.
    Jin T; Bokarewa M; Foster T; Mitchell J; Higgins J; Tarkowski A
    J Immunol; 2004 Jan; 172(2):1169-76. PubMed ID: 14707093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning & expression of SAK enzyme from
    Muttar A; Numan IT
    J Med Life; 2022 Jun; 15(6):768-771. PubMed ID: 35928367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.